Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines

IMPORTANCE: Extremely preterm (EP) infants frequently receive opioids and/or benzodiazepines, but these drugs’ association with neurodevelopmental outcomes is poorly understood. OBJECTIVES: To describe the use of opioids and benzodiazepines in EP infants during neonatal intensive care unit (NICU) ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Puia-Dumitrescu, Mihai, Comstock, Bryan A., Li, Sijia, Heagerty, Patrick J., Perez, Krystle M., Law, Janessa B., Wood, Thomas R., Gogcu, Semsa, Mayock, Dennis E., Juul, Sandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264640/
https://www.ncbi.nlm.nih.gov/pubmed/34232302
http://dx.doi.org/10.1001/jamanetworkopen.2021.15998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264640/
https://www.ncbi.nlm.nih.gov/pubmed/34232302
http://dx.doi.org/10.1001/jamanetworkopen.2021.15998

Ejemplares similares